RBC Life Sciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RBCL research report →
Price Chart
About the company
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products. The company offers wellness products, weight loss, sports, and fitness products.
- CEO
- David Price
- IPO
- 2000
- Employees
- 89
- HQ
- Irving, TX, US
Get TickerSpark's AI analysis on RBCL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.55K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 5.84
- Div Yield
- 0.00%
- Gross Margin
- 52.82%
- Op Margin
- -2.59%
- Net Margin
- -2.93%
- ROE
- -10.08%
- ROIC
- -8.78%
Latest fiscal year · YoY change
- Revenue
- $25.77M+5.8%
- Gross Profit
- $13.61M+1.1%
- Op Income
- $-666,283
- Net Income
- $-756,284-1.9%
- EPS
- $-0.34+0.0%
- OCF Growth
- +103.7%
- FCF Growth
- +100.2%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 4.55
- RSI (14)
- 97
- Avg Volume
- 6
No earnings-call transcripts are available for RBCL yet.
- Free Float
- 91.6%
- Shares Outstanding
- 2.21M
- Float Shares
- 2.03M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 16, 13 | TYSINGER CYNTHIA L | other | 360 |
| Dec 11, 12 | TYSINGER CYNTHIA L | other | 1,800 |
| Dec 22, 09 | Price John W | other | 3,000 |
| Jan 1, 09 | Price John W | other | 200,000 |
| Dec 17, 08 | Price John W | other | 2,400 |
| Dec 17, 08 | Price John W | other | 29,900 |
| Feb 18, 08 | Price John W | other | 1,200 |
| Feb 18, 08 | Price John W | other | 1,200 |
| Nov 29, 07 | Price John W | other | 1,200 |
| Oct 16, 08 | Price John W | other | 200,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RBCL coverage
Recent articles, reports, and earnings notes.
No research on RBCL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RBCL report →Head-To-Head Analysis: Senestech (NASDAQ:SNES) vs. RBC Life Sciences (OTCMKTS:RBCL)
defenseworld.net · Apr 14
Owens & Minor (NYSE:OMI) versus RBC Life Sciences (OTCMKTS:RBCL) Head to Head Survey
defenseworld.net · Jan 31
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.